vs
Side-by-side financial comparison of Sunshine Biopharma Inc. (SBFM) and Velo3D, Inc. (VELO). Click either name above to swap in a different company.
Velo3D, Inc. is the larger business by last-quarter revenue ($9.4M vs $8.6M, roughly 1.1× Sunshine Biopharma Inc.). Sunshine Biopharma Inc. runs the higher net margin — -25.0% vs -231.9%, a 207.0% gap on every dollar of revenue. On growth, Sunshine Biopharma Inc. posted the faster year-over-year revenue change (-10.6% vs -25.2%). Sunshine Biopharma Inc. produced more free cash flow last quarter ($-1.6M vs $-8.3M). Over the past eight quarters, Sunshine Biopharma Inc.'s revenue compounded faster (6.6% CAGR vs -1.8%).
Sunshine Biopharma Inc. is a clinical-stage biopharmaceutical company focused on researching, developing and commercializing innovative therapies for oncology, neurodegenerative disorders and infectious diseases. It targets unmet medical needs across global markets, with a pipeline of targeted therapeutic candidates designed to improve patient treatment outcomes.
Velo3D, Inc. develops and sells advanced end-to-end metal additive manufacturing (3D printing) solutions, comprising industrial-grade printers, specialized processing software, and high-performance metal materials. It primarily serves global aerospace, defense, energy, semiconductor and industrial manufacturing markets, enabling customers to produce complex, high-precision metal parts that are difficult to manufacture with traditional methods.
SBFM vs VELO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $8.6M | $9.4M |
| Net Profit | $-2.1M | $-21.9M |
| Gross Margin | 35.3% | -73.6% |
| Operating Margin | -20.9% | -231.0% |
| Net Margin | -25.0% | -231.9% |
| Revenue YoY | -10.6% | -25.2% |
| Net Profit YoY | 0.8% | -2.9% |
| EPS (diluted) | — | $-0.87 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $8.6M | $9.4M | ||
| Q3 25 | $9.4M | $13.6M | ||
| Q2 25 | $9.4M | $13.6M | ||
| Q1 25 | $8.9M | $9.3M | ||
| Q4 24 | $9.6M | $12.6M | ||
| Q3 24 | $8.4M | $8.2M | ||
| Q2 24 | $9.3M | $10.3M | ||
| Q1 24 | $7.5M | $9.8M |
| Q4 25 | $-2.1M | $-21.9M | ||
| Q3 25 | $-883.8K | $-11.2M | ||
| Q2 25 | $-1.8M | $-13.3M | ||
| Q1 25 | $-1.2M | $-25.0M | ||
| Q4 24 | $-2.2M | $-21.3M | ||
| Q3 24 | $-1.2M | $-21.9M | ||
| Q2 24 | $-494.3K | $935.0K | ||
| Q1 24 | $-1.3M | $-27.5M |
| Q4 25 | 35.3% | -73.6% | ||
| Q3 25 | 32.6% | 3.2% | ||
| Q2 25 | 36.4% | -11.7% | ||
| Q1 25 | 30.7% | 7.5% | ||
| Q4 24 | 32.2% | -3.5% | ||
| Q3 24 | 34.0% | 49.4% | ||
| Q2 24 | 25.3% | -28.0% | ||
| Q1 24 | 31.2% | -28.8% |
| Q4 25 | -20.9% | -231.0% | ||
| Q3 25 | -11.5% | -73.3% | ||
| Q2 25 | -21.8% | -85.4% | ||
| Q1 25 | -14.6% | -123.6% | ||
| Q4 24 | -21.7% | -167.0% | ||
| Q3 24 | -13.1% | -213.8% | ||
| Q2 24 | -13.6% | -187.7% | ||
| Q1 24 | -17.9% | -211.1% |
| Q4 25 | -25.0% | -231.9% | ||
| Q3 25 | -9.4% | -82.0% | ||
| Q2 25 | -18.8% | -97.7% | ||
| Q1 25 | -13.3% | -268.4% | ||
| Q4 24 | -22.5% | -168.5% | ||
| Q3 24 | -14.2% | -265.3% | ||
| Q2 24 | -5.3% | 9.0% | ||
| Q1 24 | -17.0% | -281.2% |
| Q4 25 | — | $-0.87 | ||
| Q3 25 | $-0.54 | $-0.65 | ||
| Q2 25 | $-0.82 | $-0.94 | ||
| Q1 25 | $-0.44 | $-1.87 | ||
| Q4 24 | $49.77 | $7.06 | ||
| Q3 24 | $-11.61 | $-35.52 | ||
| Q2 24 | $-43.48 | $1.65 | ||
| Q1 24 | $-2.00 | $-55.51 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $39.0M |
| Total DebtLower is stronger | — | $31.0M |
| Stockholders' EquityBook value | $23.0M | $38.2M |
| Total Assets | $30.1M | $105.3M |
| Debt / EquityLower = less leverage | — | 0.81× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $39.0M | ||
| Q3 25 | — | $11.8M | ||
| Q2 25 | — | $854.0K | ||
| Q1 25 | — | $3.9M | ||
| Q4 24 | — | $1.2M | ||
| Q3 24 | — | $1.6M | ||
| Q2 24 | — | $3.2M | ||
| Q1 24 | — | $10.9M |
| Q4 25 | — | $31.0M | ||
| Q3 25 | — | $23.0M | ||
| Q2 25 | — | $22.5M | ||
| Q1 25 | — | $21.7M | ||
| Q4 24 | — | $5.7M | ||
| Q3 24 | — | $32.3M | ||
| Q2 24 | — | $33.5M | ||
| Q1 24 | — | $44.0M |
| Q4 25 | $23.0M | $38.2M | ||
| Q3 25 | $24.2M | $29.9M | ||
| Q2 25 | $25.7M | $21.4M | ||
| Q1 25 | $22.7M | $32.8M | ||
| Q4 24 | $23.5M | $39.7M | ||
| Q3 24 | $25.0M | $34.4M | ||
| Q2 24 | $23.5M | $52.1M | ||
| Q1 24 | $24.8M | $45.5M |
| Q4 25 | $30.1M | $105.3M | ||
| Q3 25 | $31.5M | $93.7M | ||
| Q2 25 | $32.0M | $78.4M | ||
| Q1 25 | $29.2M | $91.3M | ||
| Q4 24 | $30.6M | $89.2M | ||
| Q3 24 | $30.1M | $110.8M | ||
| Q2 24 | $29.3M | $116.7M | ||
| Q1 24 | $31.9M | $136.1M |
| Q4 25 | — | 0.81× | ||
| Q3 25 | — | 0.77× | ||
| Q2 25 | — | 1.05× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.94× | ||
| Q2 24 | — | 0.64× | ||
| Q1 24 | — | 0.97× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.6M | $-7.7M |
| Free Cash FlowOCF − Capex | $-1.6M | $-8.3M |
| FCF MarginFCF / Revenue | -18.9% | -88.3% |
| Capex IntensityCapex / Revenue | 0.0% | 6.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-5.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.6M | $-7.7M | ||
| Q3 25 | $-727.8K | $-6.0M | ||
| Q2 25 | $-1.3M | $-1.2M | ||
| Q1 25 | $-1.7M | $-12.3M | ||
| Q4 24 | $-3.4M | $-2.2M | ||
| Q3 24 | $-1.4M | $-2.0M | ||
| Q2 24 | $-4.6M | $-8.0M | ||
| Q1 24 | $-3.2M | $-20.5M |
| Q4 25 | $-1.6M | $-8.3M | ||
| Q3 25 | $-735.8K | $-6.3M | ||
| Q2 25 | $-1.4M | $-3.0M | ||
| Q1 25 | $-1.7M | — | ||
| Q4 24 | $-3.5M | $-2.2M | ||
| Q3 24 | $-1.9M | $-2.0M | ||
| Q2 24 | $-5.6M | $-8.0M | ||
| Q1 24 | $-3.2M | $-20.5M |
| Q4 25 | -18.9% | -88.3% | ||
| Q3 25 | -7.8% | -46.5% | ||
| Q2 25 | -15.2% | -22.2% | ||
| Q1 25 | -19.3% | — | ||
| Q4 24 | -36.6% | -17.7% | ||
| Q3 24 | -22.2% | -24.2% | ||
| Q2 24 | -59.7% | -77.1% | ||
| Q1 24 | -43.1% | -209.8% |
| Q4 25 | 0.0% | 6.4% | ||
| Q3 25 | 0.1% | 2.3% | ||
| Q2 25 | 1.7% | 13.3% | ||
| Q1 25 | 0.1% | 0.0% | ||
| Q4 24 | 1.1% | 0.2% | ||
| Q3 24 | 6.1% | 0.2% | ||
| Q2 24 | 10.5% | 0.0% | ||
| Q1 24 | 0.8% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -8.52× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
